Moreover, Wang et al. indicated that MEX3A as a participant in the development and progression of pancreatic ductal adenocarcinoma, and that it could be potential prognosis indicator and therapeutic target [30]. This evidence concerns the gene MEX3A and pancreatic ductal adenocarcinoma.